Tiny Tanox Inc. should be on the verge of triumph. A drug it developed made headlines this week when it was shown to blunt peanut allergies, protecting people who could die after eating even part of a peanut.
But the drug is at the center of one of the toughest disputes in biotechnology, a decade-long battle with charges of stolen trade secrets and secret deals. The fight may delay the drug's introduction, and the company -- and the husband-and-wife scientists who started it -- may receive only a small share of the financial benefits.
